ATE381327T1 - Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis - Google Patents

Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis

Info

Publication number: ATE381327T1
Authority: AT; Austria
Prior art keywords: eczema; psoriasis; treatment; myristate; cethyl
Prior art date: 2000-05-12

Application number

AT01934672T

Other languages

English (en)

Inventor

Timothy David Meakin

Craig Leonard Heatley

Dianne Cadwallader

Original Assignee

Meracol Corp Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-12

Filing date

2001-05-11

Publication date

2008-01-15

2000-05-12 Priority claimed from NZ50452500A external-priority patent/NZ504525A/xx

2001-05-11 Application filed by Meracol Corp Ltd filed Critical Meracol Corp Ltd

2008-01-15 Application granted granted Critical

2008-01-15 Publication of ATE381327T1 publication Critical patent/ATE381327T1/de

Links

FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 title abstract 2
201000004624 Dermatitis Diseases 0.000 title abstract 2
201000004681 Psoriasis Diseases 0.000 title abstract 2
208000010668 atopic eczema Diseases 0.000 title abstract 2
229940074979 cetyl palmitate Drugs 0.000 title abstract 2
PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 title abstract 2
229940105132 myristate Drugs 0.000 title 1
TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 title 1
QAKXLTNAJLFSQC-UHFFFAOYSA-N hexadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC QAKXLTNAJLFSQC-UHFFFAOYSA-N 0.000 abstract 2
241000124008 Mammalia Species 0.000 abstract 1
239000002552 dosage form Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT01934672T 2000-05-12 2001-05-11 Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis ATE381327T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NZ50452500A NZ504525A (en)	2000-05-12	2000-05-12	Use of cetyl alcohol esters of myristic and palmitic acids to treat eczema and psoriasis
NZ50722800		2000-09-28

Publications (1)

Publication Number	Publication Date
ATE381327T1 true ATE381327T1 (de)	2008-01-15

Family

ID=26652173

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01934672T ATE381327T1 (de)	2000-05-12	2001-05-11	Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis

Country Status (8)

Country	Link
EP (1)	EP1335719B1 (de)
AT (1)	ATE381327T1 (de)
AU (2)	AU6083301A (de)
CA (1)	CA2408541C (de)
CY (1)	CY1107242T1 (de)
DE (1)	DE60132008T2 (de)
ES (1)	ES2298237T3 (de)
WO (1)	WO2001085163A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030153620A1 (en)	2000-05-12	2003-08-14	Meakin Timothy David	Treating eczema and/or psoriasis
US6696491B2 (en) *	2000-05-12	2004-02-24	Meracol Corporation Limited	Treating irritable bowel syndrome or disease
NZ533370A (en)	2004-06-03	2006-11-30	Meracol Corp Ltd	Use of cetyl myristate and cetyl palmitate in therapy for multiple sclerosis
EP2149375A1 (de)	2008-07-28	2010-02-03	Despharma Kft.	Zusammensetzungen zur Behandlung von dermatologischen Krankheiten und Verwendungen dafür
EP2441441A1 (de)	2010-10-14	2012-04-18	Deva Holding Anonim Sirketi	Siebverfahren für Cetylmyristat und/oder Cetylpalmitat
EP2441446A1 (de)	2010-10-14	2012-04-18	Deva Holding Anonim Sirketi	Verwendung von Supersprengmittel in Cetylmyristat und/oder Cetylpalmitatformulierungen
EP2441444A1 (de)	2010-10-14	2012-04-18	Deva Holding Anonim Sirketi	Formulierungen von Cetylmyristat und/oder Cetylpalmitat
EP2589378A1 (de)	2010-10-14	2013-05-08	Deva Holding Anonim Sirketi	Cetylmyristat- und/oder Cetylpalmitatteilchenbeschichtung
EP2471514A1 (de)	2010-12-29	2012-07-04	Deva Holding Anonim Sirketi	Kontrollierter Feuchtigkeitsgehalt von Cetyl Myristat und/oder Cetyl Palmitat Granulaten oder Formulierungen
EP2471386A1 (de)	2010-12-29	2012-07-04	Deva Holding Anonim Sirketi	Suspensionsformulierungen für Cetylmyristat und/oder Cetylpalmitat
EP2471384A1 (de)	2010-12-29	2012-07-04	Deva Holding Anonim Sirketi	Suspensions Formulierungen für Cetyl myristat und/oder Cetyl palmitat
EP2471385A1 (de)	2010-12-29	2012-07-04	Deva Holding Anonim Sirketi	Suspensionsformulierungen für Cetylmyristat und/oder Cetylpalmitat
EP2471528A1 (de)	2010-12-29	2012-07-04	Deva Holding Anonim Sirketi	Eine Herstellungsmethode für Cetyl Myristat und/oder Cetyl Palmitat Suspensionen
EP2471387A1 (de)	2010-12-29	2012-07-04	Deva Holding Anonim Sirketi	Suspensionsformulierungen für Cetylmyristat und/oder Cetylpalmitat
ES2538079T3 (es)	2011-05-23	2015-06-17	Deva Holding Anonim Sirketi	Distribución de tamaño de partícula del miristato de cetilo y/o palmitato de cetilo
EP2526931B1 (de)	2011-05-23	2014-12-17	Deva Holding Anonim Sirketi	Nasse Granulationsmethoden für Cetylmyristat und/oder Cetylpalmitat

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU195729B (en) *	1985-02-05	1988-07-28	Sandoz Ag	Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
DE4308282C2 (de) *	1993-03-16	1994-12-22	Beiersdorf Ag	Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices
US5886038A (en) *	1998-03-24	1999-03-23	Panda Pharmaceuticals, L.L.C.	Composition and method for treatment of psoriasis
DE19819273A1 (de) *	1998-04-30	1999-11-11	Pharmatec International S Giul	Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung
WO1999060167A1 (en) *	1998-05-21	1999-11-25	Isis Pharmaceuticals, Inc.	Compositions and methods for topical delivery of oligonucleotides
GB9810949D0 (en) *	1998-05-22	1998-07-22	Hewlett Healthcare Limited	Formulation
US6284234B1 (en) *	1998-08-04	2001-09-04	Johnson & Johnson Consumer Companies, Inc.	Topical delivery systems for active agents
BR0010354A (pt) *	1999-05-07	2002-03-05	Pharmasol Gmbh	Partìculas de lipìdeo à base em misturas de lipìdeos lìquidos e sólidos e método para a sua produção
US6696491B2 (en) *	2000-05-12	2004-02-24	Meracol Corporation Limited	Treating irritable bowel syndrome or disease

2001
- 2001-05-11 CA CA002408541A patent/CA2408541C/en not_active Expired - Fee Related
- 2001-05-11 AT AT01934672T patent/ATE381327T1/de active
- 2001-05-11 ES ES01934672T patent/ES2298237T3/es not_active Expired - Lifetime
- 2001-05-11 AU AU6083301A patent/AU6083301A/xx active Pending
- 2001-05-11 AU AU2001260833A patent/AU2001260833B2/en not_active Ceased
- 2001-05-11 EP EP01934672A patent/EP1335719B1/de not_active Expired - Lifetime
- 2001-05-11 DE DE60132008T patent/DE60132008T2/de not_active Expired - Lifetime
- 2001-05-11 WO PCT/NZ2001/000085 patent/WO2001085163A1/en not_active Ceased
2008
- 2008-03-17 CY CY20081100293T patent/CY1107242T1/el unknown

Also Published As

Publication number	Publication date
CA2408541A1 (en)	2001-11-15
EP1335719A4 (de)	2004-02-25
DE60132008T2 (de)	2008-12-11
CY1107242T1 (el)	2012-11-21
AU6083301A (en)	2001-11-20
WO2001085163A1 (en)	2001-11-15
CA2408541C (en)	2009-07-28
DE60132008D1 (de)	2008-01-31
AU2001260833B2 (en)	2005-09-29
ES2298237T3 (es)	2008-05-16
EP1335719B1 (de)	2007-12-19
EP1335719A1 (de)	2003-08-20

Similar Documents

Publication	Publication Date	Title
CY1107242T1 (el)	2012-11-21	Μυριστικο κητυλιο και παλμικο κητυλιο για τη θεραπεια του εκζεματος ή/και της ψωριασης
CY1108610T1 (el)	2014-04-09	Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
IS2241B (is)	2007-05-15	Píperasín afleiður og notkun þeirra sem bólgueyðandi miðlar
FI972086A7 (fi)	1997-05-15	Parannetun monilääkeresistenssiaktiivisuuden omaavat uudet aminohappoj ohdokset
UA26213C2 (uk)	1999-07-19	Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
BR9707233A (pt)	1999-07-20	Fenantridinas
PT705100E (pt)	2003-12-31	Guanidinas substituidas terapeuticas
EA200000994A1 (ru)	2001-02-26	Применение кабэрголина при лечении синдрома усталых ног
ES2133807T3 (es)	1999-09-16	Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteasas.
ES2149276T3 (es)	2000-11-01	Imidazo(4,5-c)piridin-4-aminas.
DK0668769T3 (da)	2000-10-02	Egebarkekstrakt-relaterede syntetiske sammensætninger og fremgangsmåde til deres anvendelse
DK0889886T5 (da)	2003-02-24	Hidtil ukendte, i 6-stilling substituerede phenanthridiner
CY1108563T1 (el)	2014-04-09	Μεθοδοι και υλικα για τη θεραπεια της ανεπαρκειας (ελλειψης) τεστοστερονης στους ανδρες
DK1039912T3 (da)	2002-10-28	Angiostatiske midler og præparater til behandling af GLC1A-glaukom
DE60132444D1 (de)	2008-03-06	Behandlung von reizkolon-syndrom oder -krankheit
ATE413179T1 (de)	2008-11-15	Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
TR199900505T2 (de)	1999-06-21
ES2106531T3 (es)	1997-11-01	Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
ATE249835T1 (de)	2003-10-15	Immunoregulator
ATE271873T1 (de)	2004-08-15	Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
BR0010560A (pt)	2002-06-04	3-piridil-4-arilpirrois substituìdos e métodos terapêuticos e profiláticos relacionados
LV11593A (lv)	1996-12-20	Dimetikona pielietojums aizcietejumu arstesana
DE69230644D1 (de)	2000-03-09	Verwendung von protease nexin-i als mittel gegen entzündungen
BR0015121A (pt)	2002-07-02	Composição farmacêutica utilizável para o tratamento de inflamação em humanos, e, método de tratamento de inflamação
TR199800705T2 (de)	1998-09-21

Legal Events

Date

Code

Title

Description

2008-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1335719

Country of ref document: EP